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Innate immunity offers the first line of defense against infections and other types of danger such as tumorigenesis. Its discov-
ery provides tremendous therapeutic opportunities for numerous human diseases. Delving into the structural basis of signal 
transduction by innate immune receptors, our lab has recently helped to establish the new paradigm in which innate immune 
receptors transduce ligand-binding signals through formation of higher-order assemblies containing intracellular adapters, sig-
naling enzymes and their substrates. These large signalosome assemblies may be visible under light microscopy as punctate 
structures in the μm scale, connecting to the underlying molecular structures in the nm scale. They drive proximity-induced 
enzyme activation, and provide a mechanism for signaling amplification by nucleated polymerization. These supramolecular 
signaling complexes also open new questions on their cellular organization and mode of regulation, pose challenges to our 
methodology, and afford valuable implications in drug discovery against these medically important pathways. 
innate immunity, caspase-recruitment domain, pyrin domain, supramolecular organizing centers, filament 
 
Citation:  Qiao Q, Wu H. Supramolecular organizing centers (SMOCs) as signaling machines in innate immune activation. Sci China Life Sci, 2015, 58: 




1  The innate immune system 
The effects of innate immune activation have been likely 
known for as long as humans emerged, and documented for 
thousands of years as fever, heat, redness, swelling and 
pain. The use of infection to induce immune protection 
against tumors has been widely experimented with for can-
cer therapy since more than 100 years ago, one example 
being in the treatment of malignant tumors by repeated bac-
terial inoculations to induce acute erysipelas [1]. However, 
it was not until recently when receptors that directly recog-
nize conserved features of pathogens were identified that 
our understanding on innate immunity started to grow ex-
ponentially [2–4], representing a revolution in immunology. 
We now know that innate immunity is an equally important 
component of host defense as adaptive immunity. Because 
innate immunity uses germline-encoded receptors [2,5], it is 
immediate and acts before adaptive immunity has a chance 
to generate clonal selection mediated specific protection. 
Innate immunity also operates as the co-stimulator for adap-
tive immunity, and accounts for the indispensable role of 
adjuvants as the immunologist’s “dirty little secret” in vac-
cination [2,6,7]. While adaptive immunity is limited to ver-
tebrates, innate immunity is evolutionarily conserved and 
has been perfected over millions of years [8]. 
The innate immune system may be considered to com-
prise pattern recognition receptors (PRRs) that directly react 
to incoming danger signals and cytokine receptors that am-
plify the initial responses [9]. A number of families of PRRs 
have been characterized (Figure 1). While the Toll-like re-
ceptor (TLR) family detects extrinsic pathogenic signals 





























Figure 1  Overview of innate immune signaling pathways. The Toll-like receptor (TLR) family detects conserved pathogen-associated molecules such as 
flagellin and lipopolysaccharide (LPS) in the extracellular environment and recruits intracellular signaling adapters myeloid differentiation primary response 
gene 88 (MyD88) and MyD88 adapter-like (Mal) through TIR domain interactions. Binding of interleukin-1 receptor associated kinases (IRAKs) to MyD88 
to assemble the Myddosome leads to activation of these kinases and induction of NF-B and IRF transcriptional activities. RIG-I-like receptor (RLR) family 
senses intracellular viral RNAs. Through promoting mitochondrial antiviral-signaling protein (MAVS) filament formation, an RLR eventually activates IRF, 
leading to secretion of type I interferons. The cyclic GMP-AMP synthase (cGAS) recognizes cytosolic DNA and produces cyclic GMP-AMP (cGAMP) as a 
secondary messenger. cGAMP and bacterial c-di-GMP activate stimulator of interferon genes (STING) and result in IRF activation. The nucleotide-binding 
domain and leucine-rich domain containing receptors (NLR) and absent in melanoma 2 (AIM2)-like receptors (ALR) respond to large varieties of pathogenic 
signals in the cytosol and outside the cell. The adaptor apoptosis-associated speck-like protein containing a CARD (ASC) can be recruited through receptor 



















Figure 2  Zoom into the signaling puncta. A, Confocal microscopy shows upon stimulation, CARMA1, Bcl10 and MALT1 assemble into punctate struc-
tures in T-cells [47]. In vitro reconstituted CBM complex reveals a filamentous morphology under the electron microscope. Further structural studies identi-
fied the core part of the complex as the Bcl10 CARD filament in a helical symmetry [30]. B, Inflammasome puncta under the confocal microscope [48] and 
electron microscope [31]. In vitro reconstituted NLRP3 inflammasome was observed as bundles filaments. An ASC PYD helical filament structure was 
solved by cryo-EM at 3.8 Å resolution [31]. 
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and intrinsic dangers on the cell surface and in the endo-
some [10,11], the RIG-I-like receptor (RLR) family senses 
intracellular viral RNAs [12]. They both activate nuclear 
factor B (NF-B) and interferon regulatory factor (IRF) 
transcription factors to induce cytokine production. The 
nucleotide-binding domain and leucine-rich domain con-
taining receptors (NLR) [13,14] and absent in melanoma 2 
(AIM2)-like receptors (ALR) [15–17] respond to a wide 
variety of pathogenic and intrinsic dangers to form inflam-
masomes, inducing caspase-1 activation, interleukin-1β 
maturation and cell death [18,19]. Some NLRs also stimu-
late NF-B and IRF activation [20]. The cyclic GMP-AMP 
synthase (cGAS) detects cytoplasmic double-stranded DNA 
to synthesize cyclic GMP-AMP (cGAMP), which in turn 
binds and activates stimulator of interferon genes (STING), 
leading to robust IRF activation [21]. Cytokines secreted 
upon PRR activation further activate cytokine receptors, 
such as those in the tumor necrosis factor receptor (TNFR), 
interleukin-1 receptor (IL-1R), and interferon receptor fami-
lies [9]. Additionally, lymphocytes also induce innate-like, 
inflammatory responses, including NF-B activation by 
T-cell receptors (TCR) and B-cell receptors (BCR) through 
the CARMA1/Bcl10/MALT1 (CBM) signaling complex 
[22,23], further expanding the role of innate immunity in 
immune responses in general. 
2  Signaling platforms formed by helical assem-
blies of death-fold domains and proximity-driven 
enzyme activation 
Our interest in innate immunity began with receptors in the 
TNFR and IL-1R families. Through biochemical and struc-
tural studies, our initial anticipation on a classical mode of 
signaling for these receptors was replaced by the new ob-
servation of higher order signaling complexes that execute 
signal transduction across the cell membrane and signal 
amplification inside the cell. A turning point in these studies 
was the realization that the family of death-fold domains, 
ubiquitously present in innate immune signaling pathways, 
assemble oligomeric complexes using helical symmetry 
[24]. Initially discovered from the cytoplasmic domain of 
TNF-R1 [25], the death-fold superfamily is composed of 
four domains, death domains (DD), caspase activation and 
recruitment domains (CARD), death-effector domains 
(DED) and pyrin domains (PYD) [26]. Structurally, all 
death-fold family members share a conserved six-helix 
bundle fold, but with distinct sequence and surface features 
for mediating specific self-association and recruitment [26].  
Through crystal structure determination, supplemented 
with imaging by electron microscopy, our laboratory dis-
covered that DDs form oligomeric complexes with unusual 
stoichiometries, such as the 5:7 binary complex in the 
PIDDosome for caspase-2 activation, the 5:5 binary com-
plex in the death inducing signaling complex, and the 6:4:4 
ternary Myddosome complex in TLR and IL-1R signal 
transduction [24,27,28]. Although the exact symmetries 
used for these assemblies differ, they are all helical symme-
tries, rather than point symmetries, which organize the death 
domain subunits into orderly structures [26]. As predicted 
by the polymerization ability of helical symmetries, many 
death-fold domains have subsequently been found to form 
helical filaments, such as the PYD and CARD in inflam-
masome structures and RIG-I signaling [29–33], further 
illuminating the higher-order nature of these complexes. 
The DD, DED, PYD and CARD often reside in proteins 
with enzyme domains such as caspase and kinase domains. 
By bringing these domains into the higher-order assemblies, 
the death-fold domain family promotes proximity-driven 
dimerization and allosteric activation of these enzymes to 
execute the signal transduction [34].  
3  Signal amplification by nucleated polymeri-
zation 
One important principle in the involvement of filaments in 
innate immune signaling is nucleated polymerization in 
which one signaling protein induces filament formation of 
another signaling protein [29–31,35]. In our study of the 
CARMA1/Bcl10/MALT1 complex, which acts downstream 
of TCR and BCR for induction of NF-B activation [30], 
we found that while Bcl10 can form filamentous structures 
on its own, CARMA1 promotes Bcl10 filament formation 
by increasing the rate and decreasing the concentration 
threshold of Bcl10 polymerization. The stimulation by 
CARMA1 enhances with an increased oligomerization state 
of CARMA1. The more aggregated CARMA1 is, the more 
potent it is in this activity, explaining over-activation of the 
pathway by highly aggregated oncogenic CARMA1 mu-
tants [36]. Our additional structure-guided studies con-
firmed that CARMA1 nucleates Bcl10 filament formation 
by providing an oligomeric platform to recruit Bcl10 for 
helical assembly [30]. Similar principles operate in the for-
mation of ALR and NLR inflammasomes and RLR signal-
ing complexes, in which the same helical symmetry is 
shared between the nucleator (e.g. CARMA1) and the pol-
ymerizer (e.g. Bcl10) [31,32,37].   
The universal mechanism of nucleated polymerization 
affords an elegant mechanism of signal transduction and 
amplification in innate immunity [34]. In a classical signal-
ing pathway such as those mediated by G-protein coupled 
receptors [38], ligand binding from outside the cell induces 
conformational changes that lead to promotion of the ex-
change of GDP for GTP of the bound heterotrimeric G pro-
teins. The GTP-bound α subunits of G proteins dissociate 
from the β and γ subunits, each effecting target proteins for 
production of second messengers such as cAMP and for 
regulation of channel activities, respectively. For innate 
immune receptors, activating stimuli induce conformational 
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changes to cause receptor clustering. Oligomerized recep-
tors act as templates to recruit downstream signaling pro-
teins to propagate the activation signal. By leading to 
polymerization of these signaling proteins, one receptor 
activates many signaling proteins, resulting in amplification 
of the signaling cascade. Therefore, nucleated polymeriza-
tion may contribute to the sensitivity and the threshold re-
sponse in the signal transduction of many innate immune 
receptors [39]. 
4  Supramolecular organizing centers (SMOCs) 
in cells 
While studies in vitro have revealed biophysical insights 
into innate immune signalling, it is essential to extend these 
understandings to cellular systems. One emerging concept is 
that innate immune receptors not only induce the formation 
of these large signalosomes, they appear to use specific cel-
lular locations for their assembly. Therefore, we previously 
put forward the concept of SMOCs as location-specific 
higher-order signalling complexes in which increased local 
concentrations of signalling components promote the intrin-
sically weak allosteric interactions required for enzyme ac-
tivation [40]. For example, the TLR signaling complex 
Myddosome is assembled at the cell surface and the endo-
some, because the sorting adaptor protein TIRAP with pro-
miscuous affinity to acidic phosphoinositides and phospha-
tidylserine on these membranes orchestrates the recruitment 
of Myddosome components [41,42]. Even though the RLRs 
are cytosolic receptors, the downstream adapter MAVS is 
localized at mitochondria, peroxisomes and the mitochon-
dria-associated membranes of the endoplasmic reticulum 
(MAM), enabling SMOC assembly at each of these orga-
nelles [43–45]. The CBM signalling complex appears to be 
associated with the p62 adapter and autophagosomes [46]. 
The implications of SMOCs are yet to be clearly resolved. 
However, borrowing from the slogan “location, location, 
location” from real estate, the specific localizations of the 
signalosomes may assist the access to certain proteins or 
factors that facilitate assembly, signal transduction and am-
plification, and the reach of a response threshold of the cel-
lular responses.  
5  Therapeutic implications 
An emerging hypothesis is that nearly every human disease 
has an inflammatory component, including cancers, auto-
immune conditions and metabolic syndromes. Structural 
and functional studies on innate immunity, which is at the 
center of inflammation, have provided a treasure trove for 
disease prevention and treatment. The discovery of the 
higher-order nature of innate immune signaling complexes 
and their specific locations offers new angles for potential 
therapeutic interventions, for example, through disruption of 
the scaffolding functions of signaling proteins in addition to 
their enzyme activities, and interference of their localiza-
tions.  
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